Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR New Investigator

Institut de recherches cliniques de Montréal

$300,000.00

Transcriptional Regulation of the Metabolic Syndrome

EF 2011-12

Résumé
Fatty liver disease affects one third of the population of North America. The disease has few symptoms, but over time leads to irreversible damage to the liver. Having a fatty liver not only increases your chance of liver failure, but also of developing other disease such as diabetes and heart problems. The cause of the disease is unknown, but being overweight dramatically increases the likelihood of being afflicted. Diets high in fat and sugar and low physical activity both contribute to the rising number of cases, particularly in children. Patients with fatty liver disease will likely face significant health problems in the future if not treated early on. There is no cure for the disease and diagnosis is difficult, mainly because we do not understand what triggers it. We have shown that low levels of a protein called PGC-1alpha in the liver may cause or worsen fatty liver disease and our new studies will help to understand how this happens. Identifying the cause of fatty liver disease will help to discover ways to diagnosis patients early and to design more effective treatments.
Programme
CIHR New Investigator
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
241395
Name
Estall Jennifer
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
New Investigators A
Projecttitle
Transcriptional Regulation of the Metabolic Syndrome
Programtype2
Salary Programs
Orgnameinp2
Institut de recherches cliniques de Montréal
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
CIHR New Investigator
Keyworddelim
Biomarker; Fatty Liver Disease; Inflammation; Insulin Resistance; Metabolism; Mitochondria; Obesity; Pgc-1alpha; Reactive Oxygen Species; Transcription
Abstract
Fatty liver disease affects one third of the population of North America. The disease has few symptoms, but over time leads to irreversible damage to the liver. Having a fatty liver not only increases your chance of liver failure, but also of developing other disease such as diabetes and heart problems. The cause of the disease is unknown, but being overweight dramatically increases the likelihood of being afflicted. Diets high in fat and sugar and low physical activity both contribute to the rising number of cases, particularly in children. Patients with fatty liver disease will likely face significant health problems in the future if not treated early on. There is no cure for the disease and diagnosis is difficult, mainly because we do not understand what triggers it. We have shown that low levels of a protein called PGC-1alpha in the liver may cause or worsen fatty liver disease and our new studies will help to understand how this happens. Identifying the cause of fatty liver disease will help to discover ways to diagnosis patients early and to design more effective treatments.
Competitiondate
201109
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Estall, Jennifer
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $300,000~ $0~